戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  weight loss, and 5% had intermittent bloody loose stool.
2 fever, associated with vomiting and frequent loose stools.
3 e, 35% had abdominal pain, 24% had nonbloody loose stool, 18% had vomiting, 18% had weight loss, and
4  (0.5 days vs 2.1 days, p=0.0006) with fewer loose stools (3.7 vs 10.5, p<0.0001) than placebo.
5  frequently in those reporting predominantly loose stools (33% vs. 12%).
6 nd their most predominant feature was bloody loose stool (78%).
7 BD exacerbations (ie, increased frequency of loose stools, abdominal pain), it is hard to differentia
8 t decrease in flatulence, intestinal cramps, loose stools and diarrhea.
9 hin 7 days of illness onset experiencing >=3 loose stools/day plus sunken eyes, poor skin turgor, dys
10 particular symptoms (stomach pain, fainting, loose stools/diarrhea, palpitations, and sleep problems)
11 ogue turbidity sensor to assess in real time loose stools for tracking of diarrhea.
12 rrheal illness <7 d duration comprising >/=3 loose stools in 24 h and >/=1 of the following: sunken e
13 (defined as maternal report of three or more loose stools in 24 h, or one loose stool with visible bl
14        Diarrhoea was graded by the number of loose stools in 24 h: mild (three), moderate (four or fi
15  years old, hospitalized with diarrhea (>/=3 loose stools in 24 hours) at two district hospitals in N
16 fined as a child 0-59 months old passing >=3 loose stools in a 24-hour period with >=1 of the followi
17 ic inflammation and has a high prevalence in loose stools in humans(1,2).
18 l pain and bloating scores of 3 or more, and loose stool, located at 270 centers in the United States
19  reported by three patients (15%), including loose stools, nausea, and bloating.
20 e loose stools of >=200 mL each, or a single loose stool of >=300 mL over a 48-h period).
21 from baseline and a decrease in frequency of loose stools of >/=50% from baseline, for 2 or more week
22 ymptomatic diarrhoea (defined as two or more loose stools of >=200 mL each, or a single loose stool o
23 oup reductions in abdominal pain (p < 0.01), loose stools (p < 0.01), bloating (p < 0.05), flatulence
24 e diarrhoea (defined by WHO as three or more loose stools per day for less than 14 days).
25 We defined clinical failure as diarrhea (>=3 loose stools per day) for >=1 day after treatment finish
26               Patients with fewer than three loose stools per day, more than 7 days of symptoms, prev
27 ossibility when the patient has fewer than 3 loose stools per day; the glutamate dehydrogenase test f
28 with chronic diarrhea, defined as passage of loose stools three or more times per week for 6 months,
29 lated gastrointestinal side effects (nausea, loose stools, vomiting) were common but did not limit th
30 ed daily gastrointestinal symptoms (vomiting/loose stools), weekly stool swabs, and healthcare data u
31            Secondary hyperparathyroidism and loose stools were more frequent after distal gastric byp
32 f three or more loose stools in 24 h, or one loose stool with visible blood) were identified through
33 f a stool specimen, and having three or more loose stools within 24 h with the presence of dehydratio
34 s return, he developed diarrhea, cramps, and loose stools without blood or mucus in the absence of fe